Drug_ID,Drug,Y
AVE0118,COc1ccc(CC(=O)NCc2ccccc2-c2ccccc2C(=O)NCCc2cccnc2)cc1,1.0
WOMBAT38,Fc1ccc2c([C@@H]3C[NH2+]CC[C@@H]3F)c(C3=CNC=CC3)[nH]c2c1,1.0
OXAPROZIN,O=C([O-])CCc1nc(-c2ccccc2)c(-c2ccccc2)o1,0.0
BRL-37872,COc1ccc(CC[NH+](C)CCCN(C(=O)c2ccc([N+](=O)[O-])cc2)c2ccc(OC)c(OC)c2)cc1OC,1.0
TIZANIDINE,Clc1ccc2nsnc2c1NC1=[NH+]CCN1,0.0
NELFINAVIR,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)C[NH+]1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,1.0
ANASTROZOLE,CC(C)(C#N)c1cc(Cn2cncn2)cc(C(C)(C)C#N)c1,0.0
MELOXICAM,Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1,0.0
WOMBAT06,c1ccc(-c2[nH]c3ccccc3c2C2CCN(c3ccccc3)CC2)cc1,1.0
FENTANYL,CCC(=O)N(c1ccccc1)C1CC[NH+](CCc2ccccc2)CC1,1.0
ERYTHROMYCYLAMINE,CC[C@H]1OC(=O)[C@@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H]([NH+](C)C)[C@@H]2O)[C@@](C)(O)C[C@@H](C)[C@H]([NH3+])[C@H](C)[C@@H](O)[C@]1(C)O,0.0
ALVIMOPAN,C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)NCC(=O)O)CC[C@@]1(C)c1cccc(O)c1,0.0
DROPERIDOL,O=C(CCC[NH+]1CC=C([N+]2=c3ccccc3=NC2=O)CC1)c1ccc(F)cc1,1.0
WOMBAT57,N#Cc1ccc(Cn2cncc2C[NH+](CC[NH+]2CCOCC2)[C@@H]2CCN(Cc3cccc(Cl)c3)C2=O)cc1,1.0
VINPOCETINE,CCOC(=O)C1=C[C@]2(CC)CCC[NH+]3CCc4c(n1c1ccccc41)[C@H]32,1.0
VINPOCETINE,CCOC(=O)C1=C[C@]2(CC)CCC[NH+]3CCc4c(n1c1ccccc41)[C@@H]32,1.0
BMCL20031829_03,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccccc23)CC1,1.0
BMCL20031829_08,COC(=O)c1ccc(-n2cc(C3CCN(CCN4CCNC4=O)CC3)c3cc(Cl)ccc32)cc1,1.0
BMCL20031829_04,O=C(O)Cc1ccc(-n2cc(C3CCN(CCN4CCNC4=O)CC3)c3cc(Cl)ccc32)cc1,1.0
BMCL20031829_01,O=C1NCCN1CCN1CCC(c2cn(-c3ccccc3)c3ccc(Cl)cc23)CC1,1.0
SERTINDOLE3,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,1.0
BMCL20031829_05,O=C(O)c1ccc(-n2cc(C3CCN(CCN4CCNC4=O)CC3)c3cc(Cl)ccc32)cc1,0.0
BMCL20031829_07,COC(=O)Cc1ccc(-n2cc(C3CCN(CCN4CCNC4=O)CC3)c3cc(Cl)ccc32)cc1,1.0
AF3013,C[C@H]1Sc2c(C(=O)O)c(=O)c3cc(F)c(N4CCNCC4)cc3n21,0.0
DASATINIB,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,1.0
SAQUINAVIR,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2C[NH+]1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,1.0
EGIS7229,COc1ccc(CC[NH+](C)CCCNc2c(Cl)cn[nH]c2=O)cc1OC,1.0
AMINOMETHYL TETRAHYDRONAPHTHALENE KETOPIPERAZINE 4B,O=C1CN(CCc2ccc(F)cc2)CCN1[C@H]1CCc2cc(Cn3ccnc3)ccc2C1,1.0
ranolazine,COc1ccccc1OCC(O)C[NH+]1CC[NH+](CC(=O)Nc2c(C)cccc2C)CC1,1.0
RANOLAZINE,COc1ccccc1OC[C@H](O)C[NH+]1CC[NH+](CC(=O)Nc2c(C)cccc2C)CC1,1.0
DILTIAZEM,COc1ccc([C@@H]2Sc3ccccc3N(CC[NH+](C)C)C(=O)[C@@H]2OC(C)=O)cc1,1.0
ICI-118551,Cc1ccc(OC[C@H](O)[C@H](C)NC(C)C)c2c1CCC2,1.0
,C#CCSc1n[nH]c(-c2ccco2)n1,0.0
"5-CHLORO-N-[3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)PROPYL]-N-METHYL-1-BENZOFURAN-2-CARBOXAMIDE",CN(CCCN1c2ccccc2CCc2ccccc21)C(=O)c1cc2cc(Cl)ccc2o1,1.0
WOMBAT11,N#Cc1ccc(Cn2cncc2C[NH2+][C@@H]2CCN(C(=O)c3cccnc3[S-])C2=O)cc1,1.0
WOMBAT66,N#Cc1ccc(Cn2cncc2C[NH2+][C@@H]2CCN(C(=O)c3cncc(Br)c3)C2=O)cc1,1.0
WOMBAT17,CCSc1ncccc1C(=O)N1CC[C@@H]([NH2+]Cc2cncn2Cc2ccc(C#N)cc2)C1=O,1.0
WOMBAT22,COc1ncccc1C(=O)N1CC[C@H]([NH2+]Cc2cncn2Cc2ccc(C#N)cc2)C1=O,1.0
WOMBAT25,Cc1ncccc1C(=O)N1CC[C@H]([NH2+]Cc2cncn2Cc2ccc(C#N)cc2)C1=O,1.0
WOMBAT23,N#Cc1ccc(Cn2cncc2C[NH2+][C@H]2CCN(C(=O)c3cccnc3[O-])C2=O)cc1,0.0
WOMBAT24,N#Cc1ccc(Cn2cncc2C[NH2+][C@@H]2CCN(C(=O)c3cccnc3N)C2=O)cc1,0.0
WOMBAT18,CSc1ncccc1C(=O)N1CC[C@@H]([NH2+]Cc2cncn2Cc2ccc(C#N)cc2)C1=O,1.0
,Fc1ccc(-n2cc(C3CCN(CCN4CCNC4=S)CC3)c3ccccc32)cc1,1.0
VARDENAFIL,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CC[NH+](CC)CC4)ccc3OCC)[nH]n12,1.0
norpropoxyphene,CCC(=O)OC(Cc1ccccc1)(c1ccccc1)C(C)C[NH2+]C,1.0
NORPROPOXYPHENE,CCC(=O)O[C@](Cc1ccccc1)(c1ccccc1)[C@H](C)C[NH2+]C,1.0
Wombat1,Fc1ccc2c(C3C[NH2+]CCC3F)c(-c3ccsc3)[nH]c2c1,1.0
WOMBAT01,Fc1ccc2c([C@@H]3C[NH2+]CC[C@H]3F)c(-c3ccsc3)[nH]c2c1,1.0
FLUVASTATIN,CC(C)n1c(/C=C\[C@@H](O)C[C@@H](O)CC(=O)[O-])c(-c2ccc(F)cc2)c2ccccc21,0.0
NEBIVOLOL,O[C@H](CNC[C@@H](O)[C@H]1CCc2cc(F)ccc2O1)[C@H]1CCc2cc(F)ccc2O1,1.0
CLOZAPINE_N_OXYDE,C[NH+]1CC[NH+]([C@@H]2c3ccccc3Nc3ccc(Cl)cc3N2O)CC1,0.0
VENLAFAXINE,COc1ccc(C(C[NH+](C)C)C2(O)CCCCC2)cc1,1.0
DULOXETINE,CN(C)C[C@@H](c1ccc(O)cc1)C1(O)CCCCC1,1.0
DESVENLAFAXINE,CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1,0.0
OXYBUTYNIN,CC[NH+](CC)CC#CCOC(=O)[C@@](O)(c1ccccc1)C1CCCCC1,1.0
OXYBUTYNIN,CC[NH+](CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1,1.0
GREPAFLOXACIN,Cc1c(F)c(N2CC[NH2+][C@H](C)C2)cc2c1C(=O)[C@H](C(=O)[O-])C=[N+]2C1CC1,0.0
SPARFLOXACIN,C[C@H]1CN(c2c(F)c(N)c3c(c2F)[N+](C2CC2)=C[C@@H](C(=O)[O-])C3=O)C[C@@H](C)[NH2+]1,1.0
GATIFLOXACIN,COc1c(N2CC[NH2+][C@H](C)C2)c(F)cc2c1[N+](C1CC1)=C[C@@H](C(=O)[O-])C2=O,0.0
TAMOXIFENE,CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,1.0
TAMOXIFEN,CC/C(=C(/c1ccccc1)c1ccc(OCC[NH+](C)C)cc1)c1ccccc1,1.0
CLOMIPHENE,CC[NH+](CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1,1.0
METHOXYVERAPAMIL,COc1ccc(CCN(C)CCC[C@@](C#N)(c2cc(OC)c(OC)c(OC)c2)C(C)C)cc1OC,1.0
HALOPERIDOL,O=C(CCC[NH+]1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,1.0
RALTEGRAVIR,Cc1nnc(C(=O)NC(C)(C)C2=N/C(=C(\O)NCc3ccc(F)cc3)C(=O)C(=O)N2C)o1,0.0
L-691121,CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccc4nonc4c3)CC1)O2,1.0
